García-Díaz N, Wei Q, Taskén K(2023) Small molecule inhibitors targeting regulatory T cells for cancer treatment Eur J Immunol, e2350448(in press) DOI 10.1002/eji.202350448, PubMed 37937687
Le Tourneau C, André F, Helland Å, Mileshkin L, Minnaard W, Schiel A, Taskén K, Thomas DM, Veronese ML, Durán-Pacheco G, Leyens L, Rufibach K, Thomas M, Krämer A(2023) Modified study designs to expand treatment options in personalised oncology: a multistakeholder view Eur J Cancer, 194, 113278 DOI 10.1016/j.ejca.2023.113278, PubMed 37820553
Spasevska I, Sharma A, Steen CB, Josefsson SE, Blaker YN, Kolstad A, Rustad EH, Meyer S, Isaksen KT, Chellappa S, Kushekhar K, Beiske K, Førsund MS, Spetalen S, Holte H, Ostenstad B, Brodtkorb M, Kimby EK, Olweus J, Taskén K, Newman AM, Lorenz S, Smeland EB, Alizadeh AA, Huse Ket al.(2023) Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma Blood Adv(in press) DOI 10.1182/bloodadvances.2023010158, PubMed 37695745
